intolerance in association with liver disease is well known and galactose challenge has been used as a dynamic test of liver function.3 Pronounced galactose intolerance, however, is usually associated with severe liver disease.2 Hepatosplenomegaly was not noted in this infant and biochemical evidence was limited to moderate transient abnormalities of alkaline phosphatase, y-glutamyltransferase, albumin, and a persisting borderline rise of transaminase activities. Early jaundice and anaemia are both features of galactosaemia; however, the jaundice was transient, and both prematurity and frequent blood sampling may have been contributory factors.
This child appears to be unusual in the degree of his intolerance to galactose in the absence of any detectable defect in galactose pathways and in the presence of only minimal biochemical evidence of liver disease. This intolerance appeared to be physiological as well as biochemical as the child's health improved promptly when he was given a galactose free diet. It appears unlikely that the biochemical and clinical improvements were unrelated. It is important that children with galactose intolerance other than that due to inherited enzyme deficiencies be challenged with galactose at intervals so that they can return to normal feeds as soon as they are able to tolerate them.
sumMARY Eighty four very low birthweight babies (considered high risk for developing necrotising enterocolitis) were given vancomycin orally for 48 hours before introduction of oral feeds; one developed necrotising enterocolitis. One hundred and twenty very low birthweight babies (not considered such high risk) were fed without first receiving vancomycin; 17 developed necrotising enterocolitis. Although this was not a randomised control trial, results indicate a role for vancomycin in prophylaxis of necrotising enterocolitis.
The exact sequence of pathological events in necrotising enterocolitis has not been established, although there is general agreement that prematurity and neonatal illness predispose to it, and that invasion of the bowel wall by bacteria is the ultimate and most serious aspect of the pathological process. It is also widely accepted that necrotising enterocolitis rarely develops in babies who have not received enteral feeds and indeed often manifests soon after feeds have been introduced. It could be that gut bacteria require food substrate in order to multiply sufficiently to invade the susceptible bowel wall. Ifthis hypothesis is correct, then reducing the bacterial population in the bowel, particularly the gas producing anaerobes, before introducing milk feeds could reduce the incidence of necrotising enterocolitis.
According to this line of reasoning it has been our policy, during the past three years, to treat very low birthweight babies who have had prolonged intensive care, and are therefore at high risk of developing necrotising enterocolitis, with oral vancomycin for 48 hours before starting milk feeds. Vancomycin was chosen because of its activity against clostridial species and other anaerobes, and because it does not completely sterilise the bowel, which could promote colonisation by unwanted pathogens. Furthermore, vancomycin is poorly absorbed and so a high drug concentration can be achieved in the gut with minimal risk of systemic toxicity. This paper presents our experience with necrotis- Milk feeds were given as intermittent boluses, starting at 1 ml hourly and gradually increasing according to tolerance. Babies were fed human milk whenever possible but a number of commercial formulas were also used.
With regard to outcome, babies were diagnosed as having necrotising entercolitis if they had an illness characterised by abdominal distension, blood in the stools, and intramural gas on abdominal radiography.
We used unpaired t tests for analysis of parametric data, and the Mann-Whitney U test for nonparametric data.
Results
A total of 28 babies in the group who did not receive vancomycin died within the first 5 days of life before oral feeds were considered. None of them had necrotising enterocolitis. They have been excluded from the analysis, leaving 92 babies in this group. The experience that we report in this paper does not derive from an attempt to conduct an experiment, but is rather a retrospective review of the effects of a change in clinical practice. As no attempt at randomisation was made there was inevitably bias in the allocation to treatment or non-treatment groups. Indeed there was a deliberate effort to treat with vancomycin those babies judged most susceptible to necrotising enterocolitis according to the generally accepted risk criteria, and in this sense selection bias provides an even more rigorous test of the prophylactic value of vancomycin in necrotising enterocolitis. Interestingly, the 17 babies in the group not receiving vancomycin who developed necrotising enterocolitis are not typical of the nontreatment group as a whole. In terms of the putative risk factors-namely, shorter gestation, lower birth weight, poorer condition at birth, and more prolonged ventilation-they were appreciably more at risk than the remainder of the group not receiving vancomycin. In a formal study, the 17 babies in question might have been identified as 'at risk' and therefore treated. Decision making in routine clinical practice is, however, rarely as rigorous as it might be.
While selection bias undoubtedly strengthens the conclusion that something occurring to the group receiving vancomycin resulted in a significant reduction in the expected incidence of necrotising enterocolitis, it prevents us from concluding with certainty that it was vancomycin. A possible alternative explanation is the difference between the two groups in the age at which feeds were introduced.6 The group receiving vancomycin were first fed at a mean of 24*7 days of age and the group not receiving vancomycin at a mean of 6-8 days. This difference reflects our policy of delaying the introduction of enteral feeding until babies are out of intensive care. It is important to note, however, that the 17 babies who developed necrotising enterocolitis were first .fed at a mean age of 10 days which is significantly later than the rest of the non-treatment group who escaped necrotising enterocolitis. Only a prospective randomised trial can decide whether it is the use of vancomycin or the delaying of enteral feeds (or indeed some other factor) that was responsible for preventing necrotising enterocolitis in our treatment group.
An inevitable worry associated with the widespread prophylactic use of any antibiotic is that of inducing resistance in bacteria. Vancomycin has a remarkable reputation for not doing so, and it has been in use for a long time. Further investigation of this would be desirable if vancomycin prophylaxis in the very low birthweight baby was to be generally adopted. Sexually transmitted diseases continue to be a serious public health problem all over the world. In recent years an increase in the incidence of acquired and congenital syphilis has been reported from both developed and developing countries.1 The present study, which emphasises the neonatal aspects of this disease, was undertaken to document the clinical range of congenital syphilis in the neonatal period, identify common clinical features of the disease in this age group, and assess the immediate prognosis of the disease in the neonatal period.
Patients and methods
Newborn babies included in the study were born in the greater Harare area and admitted to the neonatal unit, Harare Central Hospital, which is the referral centre for all high risk newborn babies in the city of Harare, Zimbabwe. The total number of newborns admitted to the neonatal unit during the study period, 1 January to 31 December 1986, was 5287.
The diagnosis of early congenital syphilis was based on positive serology for syphilis in mother or infant, or both, in the presence of two or more clinical signs suggestive of early congenital syphilis. 2 The clinical signs regarded as suggestive of early congenital syphilis were as follows: (a) haematological manifestations-that is, anaemia, thrombocytopenia; (b) hepatomegaly or hepatosplenomegaly; (c) jaundice; (d) mucocutaneous lesions-for example, snuffles, condylomata lata, skin rash, peeling skin of palms and soles, etc; (e) nonimmune hydrops; (f) Parrot's pseudoparalysis; and (g) radiological appearance in the long bones suggestive of congenital syphilis.
The serological tests employed for establishing the diagnosis of congenital syphilis were the rapid plasma reagin test and Treponema pallidum haemagglutination assay. A total of 53 newborn babies fulfilled the diagnostic criteria laid down above and were included in the study.
Results
The frequency of clinical features at presentation is shown in the table. Hepatomegaly or hepatosplenomegaly of 2 cm to 6 cm was present in 28 (53%) and 26 (49%) patients respectively. Clinical jaundice was noted in 25 infants (47%). Unconjugated hyperbilirubinaemia was much more common than 
